ARROWHEAD PHARMACEUTICALS, INC. Lease Agreements
9 Contracts & Agreements
- Amendment No. 5 to Lease Agreement between Arrowhead Pharmaceuticals, Inc. and University Research Park, Incorporated, dated May 14, 2020 (Filed With SEC on November 23, 2020)
- Amendment No. 4 to Lease Agreement between Arrowhead Pharmaceuticals, Inc. and University Research Park, Incorporated, dated September 19, 2019 (Filed With SEC on November 23, 2020)
- Amendment No. 3 to Lease Agreement between Arrowhead Pharmaceuticals, Inc. and University Research Park, Incorporated, dated January 11, 2019 (Filed With SEC on November 23, 2020)
- Amendment No. 2 to Lease Agreement between Arrowhead Pharmaceuticals, Inc. and University Research Park, Incorporated, dated January 10, 2019 (Filed With SEC on November 23, 2020)
- Amendment No. 1 to Lease Agreement between Arrowhead Pharmaceuticals, Inc. and University Research Park, Incorporated, dated October 22, 2018 (Filed With SEC on November 23, 2020)
- Sublease agreement by and between Halozyme, Inc. and Arrowhead Pharmaceuticals Inc. dated March 3, 2020 (Filed With SEC on May 7, 2020)
- Lease Agreement between Arrowhead Pharmaceuticals, Inc. and 177 Colorado Owner LLC, dated April 17, 2019 (Filed With SEC on August 5, 2019)
- LEASE AGREEMENT (Filed With SEC on February 9, 2016)
- OFFICE LEASE AGREEMENT BY AND BETWEEN SOUTH LAKE AVENUE INVESTORS LLC, a Delaware limited liability company AS LANDLORD and ARROWHEAD RESEARCH CORPORATION, a Delaware corporation... (Filed With SEC on May 8, 2012)
